BABAM2-AS1: A Drug Target / Disease Biomarker (G100302650)

Target Name: BABAM2-AS1

NCBI ID: G100302650

Other Name(s): BRE-AS1 | BABAM2 antisense RNA 1

BABAM2-AS1: A Drug Target / Disease Biomarker

BABAM2-AS1 is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the BABAM2 family of proteins, which are known for their role in cell signaling and inflammation. While the exact function of BABAM2-AS1 is not yet fully understood, research has shown that it is involved in a variety of physiological processes, including cell migration, invasion, and angiogenesis.

One of the most promising aspects of BABAM2-AS1 is its potential as a drug target. BABAM2-AS1 has been shown to play a role in the regulation of cell proliferation and survival, as well as in the development of cancer. Researchers have also found that BABAM2-AS1 is involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its potential as a drug target, BABAM2-AS1 has also been shown to be a valuable biomarker for a variety of diseases. For example, studies have shown that BABAM2-AS1 is often reduced in the brains of individuals with Alzheimer's disease, and that it is also decreased in the hearts of individuals with heart failure. These findings suggest that BABAM2-AS1 may be a useful diagnostic or therapeutic target for these diseases.

While more research is needed to fully understand the role of BABAM2-AS1 in these diseases, it is clear that it is an important protein that is involved in a variety of physiological processes. As such, BABAM2-AS1 is a promising candidate for further study as a drug target or biomarker.

Protein Name: BABAM2 Antisense RNA 1

More Common Targets

AREAS

Q&A

STOCKS

TARGETS

CONTACT

BD@bio.cacnex.com